JSGRX
Price
$29.27
Change
-$0.32 (-1.08%)
Updated
Jan 14 closing price
Net Assets
3.13B
RGEBX
Price
$77.85
Change
-$0.83 (-1.05%)
Updated
Jan 14 closing price
Net Assets
335.97B
Interact to see
Advertisement

JSGRX vs RGEBX

Header iconJSGRX vs RGEBX Comparison
Open Charts JSGRX vs RGEBXBanner chart's image
JHancock U.S. Growth R2
Price$29.27
Change-$0.32 (-1.08%)
VolumeN/A
Net Assets3.13B
American Funds Growth Fund of Amer R2E
Price$77.85
Change-$0.83 (-1.05%)
VolumeN/A
Net Assets335.97B
JSGRX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
JSGRX vs. RGEBX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSGRX is a Hold and RGEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 336B vs. JSGRX (3.13B). JSGRX (0.00) and RGEBX (0.00) have matching dividends . JSGRX was incepted earlier than RGEBX: JSGRX (11 years) vs RGEBX (11 years). JSGRX (1.11) and RGEBX (1.08) have similar cost to investors . JSGRX is a more actively managed with annual turnover of: 80.00 vs. RGEBX (32.00). JSGRX has a lower initial minimum investment than RGEBX: JSGRX (0) vs RGEBX (250). JSGRX (10.00) and RGEBX (9.78) have marching annual gain over last year. JSGRX return over 5 years is better than : 24.61 vs. RGEBX (17.07).
JSGRXRGEBXJSGRX / RGEBX
Total Expense Ratio1.101.08102%
Annual Report Gross Expense Ratio1.111.08103%
Fund Existence11 years11 years-
Gain YTD-0.1022.635-4%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.13B336B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.009.78102%
Returns for 3 years68.3255.10124%
Returns for 5 years24.6117.07144%
Returns for 10 years104.39114.1391%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HEQFX4.850.01
+0.21%
Monteagle Opportunity Equity Inv
TADFX8.96N/A
N/A
Transamerica Sustainable Equity Inc R6
FBTAX37.09N/A
N/A
Fidelity Advisor Biotechnology A
AGYGX12.48-0.05
-0.40%
American Century Focused Global Gr Y
HGOSX70.24-0.99
-1.39%
Hartford Growth Opportunities R4